Resultados de la búsqueda 481-490 of 7667 for 検索エンジンのソースコード 🔍 www.81.biz

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small lymphocytic lymphoma. Durvalumab is FDA approved for treatment in lung ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to explore the translational abilities of desorption electrospray ionization mass spectrometry (DESI-MS) as intraoperative ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This study aims to identify candidate High Grade Serous Cancer (HGSC) early detection and chemotherapy treatment response biomarkers.

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Levels of bladder cancer-derived extracellular vesicles become undetectable after radical cystectomy in patients with localized bladder cancer. This study hopes ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to develop preclinical models that include cell lines and patient derived xenografts (PDX) that include molecular ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This study aims to identify candidate High Grade Serous Cancer (HGSC) early detection and chemotherapy treatment response biomarkers.

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Currently, only a few international institutions use CIRT to treat pelvic bone sarcomas. Accordingly, data evaluating the potential differences in ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to develop preclinical models that include cell lines and patient derived xenografts (PDX) that include molecular ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to explore the translational abilities of desorption electrospray ionization mass spectrometry (DESI-MS) as intraoperative ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Effective treatments for recurrent gynecological cancer are lacking, and there is a need for novel therapeutic options. One of the barriers to improving ...